Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Roxlor International is a biotechnology company that specializes in the development and manufacture of innovative branded ingredients for the nutraceutical, pharmaceutical, and cosmetic industries. The company is best known for its proprietary technology used to produce Cynatine, a line of bioactive, solubilized keratin proteins derived from premium sheep's wool. These ingredients are clinically proven to support hair, skin, nail, and joint health by providing highly bioavailable sulfur-containing amino acids. Beyond keratin, Roxlor offers a range of other specialty ingredients, including SAMe and digestive health solutions, focusing on science-backed efficacy and high-quality manufacturing standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Roxlor International.